Atossa Therapeutics
ATOS
#10767
Rank
ยฃ14.34 M
Marketcap
ยฃ1.44
Share price
-1.55%
Change (1 day)
139.43%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -ยฃ28.24 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ26.31 Million a decrease over its 2024 earnings that were of -ยฃ19.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ28.24 Million7.35%
2025 -ยฃ26.31 Million36.33%
2024 -ยฃ19.3 Million-15.25%
2023 -ยฃ22.77 Million11.62%
2022 -ยฃ20.4 Million30.84%
2021 -ยฃ15.59 Million15.58%
2020 -ยฃ13.49 Million3.41%
2019 -ยฃ13.05 Million51.16%
2018 -ยฃ8.63 Million40.41%
2017 -ยฃ6.15 Million27.54%
2016 -ยฃ4.82 Million-47.49%
2015 -ยฃ9.18 Million-17.25%
2014 -ยฃ11.09 Million35.91%
2013 -ยฃ8.16 Million112.3%
2012 -ยฃ3.85 Million46.53%
2011 -ยฃ2.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.16 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.12 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.10 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.53 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ24.92 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.94 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA